Condensed Statements of Operations and Comprehensive (Loss) Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total revenue	$ 14,430	$ 14,846
Total cost of sales	6,270	6,416
Gross profit	8,160	8,430
Operating expenses:
Research and development	3,418	3,199
General and administrative	4,036	3,220
Sales and marketing	1,306	1,315
Total operating expenses	8,760	7,734
(Loss) income from operations	(600)	696
Interest expense		(63)
Other income, net	398	128
Net (loss) income and comprehensive income	$ (202)	$ 761
Net (loss) income per common share, Basic	$ (0.01)	$ 0.04
Net (loss) income per common share, Diluted	$ (0.01)	$ 0.04
Weighted-average shares of common stock outstanding, basic	21,252,359	20,450,994
Weighted average shares of common stock outstanding, Diluted	21,252,359	20,832,074
Product sales
Total revenue	$ 10,860	$ 13,777
Total cost of sales	6,002	6,123
Licensing, royalty, patent, and other revenue
Total revenue	3,570	1,069
Total cost of sales	$ 268	$ 293